Please cite this article in press Nikita Shivchand Rathod et al., Diuretics: A Review Of The Pharmacology And Effects On Glucose Homeostasis, Indo Am. J. P. Sci, 2025; 12(12).

1) Williams B, Mancia G, Spiering W, Agabiti-Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J / J Hypertens. 2018 Sep;39(33):3021–3104.
2) Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary. Circulation. 2022;145(18):e895–e1032.
3) Arumugham V, Shahin M. Therapeutic uses of diuretic agents. StatPearls. 2023 May 29.
4) Mullens W, Damman K, Testani JM, O’Connor CM, Starling RC, Tang WHW, et al. The use of diuretics in heart failure with congestion — a position paper from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019;21(2):137–155.
5) Kehrenberg MCA, Schmieder RE. Diuretics: a contemporary pharmacological classification? Clin Kidney J. 2022;15(2):xxx–xxx. (Review summarizing classes, mechanisms, and clinical uses including hypertension and kidney disease.)
6) Nazarzadeh M, Bidel Z, Canoy D, Copland E, Wamil M, Majert J, Byrne KS, Sundström J, Teo K, Davis BR, Chalmers J. Blood pressure lowering and risk of newonset type 2 diabetes: an individual participant data meta-analysis. The Lancet. 2021 Nov 13;398(10313):1803-10.
7) Scheen AJ. Type 2 diabetes and thiazide diuretics. Current diabetes reports. 2018 Feb;18(2):6.
8) Zha J, Jiang Q, Yao BB, Cohen DE, Carter DC, Menon RM. Effects of a ritonavircontaining regimen on the pharmacokinetics of sirolimus or everolimus in healthy adult subjects. Pharmacology Research & Perspectives. 2022 Dec;10(6):e01024.
9) Rosenkranz A. Hypertonie. Journal of Hypertension. 2016;20(1):26-7.
10) Arumugham V, Shahin M. Therapeutic uses of diuretic agents. StatPearls. 2023 May 29.
11) Kehrenberg MC, Bachmann HS. Diuretics: a contemporary pharmacological classification?. Naunyn-schmiedeberg’s Archives of Pharmacology. 2022 Jun;395(6):619-27.
12) Ellison DH. Clinical pharmacology in diuretic use. Clinical Journal of the American Society of Nephrology. 2019 Aug 1;14(8):1248-57.
13) Novak JE, Ellison DH. Diuretics in states of volume overload: core curriculum 2022.American Journal of Kidney Diseases. 2022 Aug 1;80(2):264-76.
14) Titko T, Perekhoda L, Drapak I, Tsapko Y. Modern trends in diuretics development.
European Journal of Medicinal Chemistry. 2020 Dec 15;208:112855.
15) Surma S, Więcek A, Adamczak M. Diuretics—a review of the current knowledge. InRenal Disease and Transplantation Forum 2023 (Vol. 16, No. 3, pp. 81-92).
16) Morales-Olivas FJ. Diuretics use in the management of hypertension. Hipertensión y Riesgo Vascular. 2024 Jul 1;41(3):186-93.
17) Kennelly P, et al. Diuretic therapy in congestive heart failure — review of classes and clinical use. (Continuing Medical Review / Intern Med). 2022.
18) Wu L, Rodriguez M, El Hachem K, Krittanawong C. Diuretic treatment in heart failure: a practical guide for clinicians. Journal of clinical medicine. 2024 Jul 30;13(15):4470.
19) Felker GM, Ellison DH, Mullens W, Cox ZL, Testani JM. Diuretic therapy for patients with heart failure: JACC state-of-the-art review. J Am Coll Cardiol.2020;75(10):1178– 1195. doi:10.1016/j.jacc.2019.12.059. PMID: 32164892.
20) Novak JE, Ellison DH. Diuretics in states of volume overload: core curriculum 2022. American Journal of Kidney Diseases. 2022 Aug 1;80(2):264-76.
21) van Poelgeest E, Prokopidis K, Erdogan T, Kwak MJ, Piotrowicz K, Paoletti L, Eidam A, Koçak FÖ, Ilhan B, Beccacece A, Soulis G. Effectiveness and safety of chronic diuretic use in older adults: an umbrella review of recently published systematic reviews and meta-analyses of randomized-controlled trials. European Geriatric Medicine. 2025 May 25:1-35.
22) Kataoka H. Proposal for new classification and practical use of diuretics according to their effects on the serum chloride concentration: rationale based on the “chloride theory”. Cardiology and Therapy. 2020 Dec;9(2):227-44.
23) Koumanov F, Pereira VJ, Richardson JD, Sargent SL, Fazakerley DJ, Holman GD. Insulin regulates Rab3–Noc2 complex dissociation to promote GLUT4 translocation in rat adipocytes. Diabetologia. 2015 Aug;58(8):1877-86.
24) Perumal V, Krishnan K, Gratton E, Dharmarajan AM, Fox SA. Number and brightness analysis of sFRP4 domains in live cells demonstrates vesicle association signal of the NLD domain and dynamic intracellular responses to Wnt3a. The international journal of biochemistry & cell biology. 2015 Jul 1;64:91-6.
25) Johnson CH, Dejea CM, Edler D, Hoang LT, Santidrian AF, Felding BH, Ivanisevic J, Cho K, Wick EC, Hechenbleikner EM, Uritboonthai W. Metabolism links bacterial biofilms and colon carcinogenesis. Cell metabolism. 2015 Jun 2;21(6):891-7.
26) Hotamisligil GS. Foundations of immunometabolism and implications for metabolic health and disease. Immunity. 2017 Sep 19;47(3):406-20.
27) Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance.
Physiological reviews. 2018 Aug 1.
28) Milovanovic D, Honigmann A, Koike S, Göttfert F, Pähler G, Junius M, Müllar S, Diederichsen U, Janshoff A, Grubmüller H, Risselada HJ. Hydrophobic mismatch sorts SNARE proteins into distinct membrane domains. Nature communications. 2015 Jan 30;6(1):5984.
29) Chua CE, Tang BL. Role of Rab GTPases and their interacting proteins in mediating metabolic signalling and regulation. Cellular and Molecular Life Sciences. 2015 Jun;72(12):2289-304.
30) Boden G, Homko C, Barrero CA, Stein TP, Chen X, Cheung P, Fecchio C, Koller S, Merali S. Excessive caloric intake acutely causes oxidative stress, GLUT4 carbonylation, and insulin resistance in healthy men. Science translational medicine. 2015 Sep 9;7(304):304re7-.
31) Sun Y, Jaldin-Fincati J, Liu Z, Bilan PJ, Klip A. A complex of Rab13 with MICAL-L2 and α-actinin-4 is essential for insulin-dependent GLUT4 exocytosis. Molecular biology of the cell. 2016 Jan 1;27(1):75-89.
32) Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006 Apr 13;440(7086):944-8.
33) Rouzine IM, Weinberger AD, Weinberger LS. An evolutionary role for HIV latency in enhancing viral transmission. Cell. 2015 Feb 26;160(5):1002-12.
34) Zhang X, Zhao Q. Association of thiazide‐type diuretics with glycemic changes in hypertensive patients: a systematic review and meta‐analysis of randomized controlled clinical trials. The Journal of Clinical Hypertension. 2016 Apr;18(4):342-51.
35) Hall JJ, Eurich DT, Nagy D, Tjosvold L, Gamble JM. Thiazide diuretic–induced change in fasting plasma glucose: a meta-analysis of randomized clinical trials. Journal of general internal medicine. 2020 Jun;35(6):1849-60.
36) Nazarzadeh M, Bidel Z, Canoy D, Copland E, Wamil M, Majert J, Byrne KS, Sundström J, Teo K, Davis BR, Chalmers J. Blood pressure lowering and risk of newonset type 2 diabetes: an individual participant data meta-analysis. The Lancet. 2021 Nov 13;398(10313):1803-10.
37) Zillich AJ, Garg J, Basu S, Bakris GL, Carter BL. Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension. 2006 Aug 1;48(2):219-24.
38) Fernando US. Monitoring of Antihypertensive Medications: A Comprehensive Guide for Safe Clinical Practice.
39) Roush GC, Sica DA. Diuretics for hypertension: a review and update. American journal of hypertension. 2016 Oct 1;29(10):1130-7.
40) Novak JE, Ellison DH. Diuretics in states of volume overload: core curriculum 2022. American Journal of Kidney Diseases. 2022 Aug 1;80(2):264-76.
41) Dietrich. Identification of Serum Metabolites Associated With Incident Hypertension in the European Prospective Investigation Into Cancer and Nutrition-Potsdam Study (vol 68, pg 471, 2016). HYPERTENSION. 2016 Dec 1;68(6):E95-.
42) Whelton PK, Bundy JD, Carey RM. Intensive blood pressure treatment goals: Evidence for cardiovascular protection from observational studies and clinical trials. American Journal of Hypertension. 2022 Nov 1;35(11):905-14.
43) Roush GC, Sica DA. Diuretics for hypertension: a review and update. American journal of hypertension. 2016 Oct 1;29(10):1130-7.
44) Rosenkranz A. Hypertonie. Journal of Hypertension. 2016;20(1):26-7.
45) Liu T, Yu B, Kakino M, Fujimoto H, Ando Y, Hakuno F, Takahashi SI. A novel IRS-1-associated protein, DGKζ regulates GLUT4 translocation in 3T3-L1 adipocytes. Scientific Reports. 2016 Oct 14;6(1):1-3.
46) Di Fulvio M, Rathod YD, Khader S. Diuretics: a review of the pharmacology and effects on glucose homeostasis. Frontiers in Pharmacology. 2025 Mar 28;16:1513125.
47) Mancia G. Preventing new-onset diabetes in thiazide-treated patients. The lancet Diabetes & endocrinology. 2016 Feb 1;4(2):90-2.
48) Li Z, Li Y, Liu Y, Xu W, Wang Q. Comparative risk of new-onset diabetes mellitus for antihypertensive drugs: a network meta-analysis. J Clin Hypertens (Greenwich).
2017;19(12):1348–1356. doi:10.1111/jch.13186. PMCID: PMC8030754.
49) Grossman A, Grossman E. Blood pressure control in type 2 diabetic patients.
Cardiovascular diabetology. 2017 Jan 6;16(1):3.
50) Whelton, P.K., Carey, R.M., Aronow, W.S., Casey, D.E., Collins, K.J., Dennison Himmelfarb, C., DePalma, S.M., Gidding, S., Jamerson, K.A., Jones, D.W. and MacLaughlin, E.J., 2018. 2017
ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology, 71(19), pp.e127-e248.
51) De Sousa EC, Abrahin O, Ferreira AL, Rodrigues RP, Alves EA, Vieira RP. Resistance training alone reduces systolic and diastolic blood pressure in prehypertensive and hypertensive individuals: meta-analysis. Hypertension Research. 2017 Nov;40(11):927-31.
52) Huynh K. Single vs bilateral artery grafts. Nature Reviews Cardiology. 2017 Jan;14(1):4-
53) Carey RM, Whelton PK. The 2017 American College of Cardiology/American Heart Association hypertension guideline: a resource for practicing clinicians. Annals of internal medicine. 2018 Mar 6;168(5):359-60.
54) Rajani R, Pastor-Soler NM, Hallows KR. Role of AMP-activated protein kinase in kidney tubular transport, metabolism, and disease. Current opinion in nephrology and hypertension. 2017 Sep 1;26(5):375-83.
55) Neal B, Perkovic V, Mahaffey KW, De Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR. Canagliflozin and cardiovascular and renal events in type 2 diabetes. New England Journal of Medicine. 2017 Aug 17;377(7):644-57.
56) Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten M, Mattheus M, Johansen
57) OE, Woerle HJ, Broedl UC, Zinman B. Empagliflozin and progression of kidney disease in type 2 diabetes. New England Journal of Medicine. 2016 Jul 28;375(4):323-
34.
58) DeFronzo RA, Norton L, Abdul-Ghani M. Renal, metabolic and cardiovascular considerations of SGLT2 inhibition. Nature Reviews Nephrology. 2017 Jan;13(1):11- 26.
59) Huynh K. Single vs bilateral artery grafts. Nature Reviews Cardiology. 2017 Jan;14(1):4-.
60) McGarrah RW, Crown SB, Zhang GF, Shah SH, Newgard CB. Cardiovascular metabolomics. Circulation research. 2018 Apr 27;122(9):1238-58.
61) Shah SH, Kraus WE, Newgard CB. Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function. Circulation. 2012 Aug 28;126(9):1110-20.
62) Sarah C. Novel probe for MRGPRX2. Nature Reviews Drug Discovery. 2017 May;16(5):314-.
63) Roush GC, Sica DA. Diuretics for hypertension: a review and update. American journal of hypertension. 2016 Oct 1;29(10):1130-7.
64) Carey RM, Whelton PK, 2017 ACC/AHA Hypertension Guideline Writing Committee*. Prevention, detection, evaluation, and management of high blood pressure in adults: synopsis of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline. Annals of internal medicine. 2018 Mar 6;168(5):351-8.
65) Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Furtado RH, Bhatt DL. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. The Lancet. 2019 Jan 5;393(10166):31-9.
66) Brown MJ, Williams B, Morant SV, Webb DJ, Caulfield MJ, Cruickshank JK, Ford I, McInnes G, Sever P, Salsbury J, Mackenzie IS. Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial. The lancet Diabetes & endocrinology. 2016 Feb 1;4(2):136-47.
67) Buhnerkempe MG, Botchway A, Prakash V, Al-Akchar M, Morales CE, Calhoun DA, Flack JM. Prevalence of refractory hypertension in the United States from 1999 to 2014. Journal of hypertension. 2019 Sep 1;37(9):1797-804.
68) Oliveira-Paula GH, Pereira SC, Tanus-Santos JE, Lacchini R. Pharmacogenomics and hypertension: current insights. Pharmacogenomics and personalized medicine. 2019 Nov 22:341-59.
69) Ansary TM, Nakano D, Nishiyama A. Diuretic effects of sodium glucose cotransporter 2 inhibitors and their influence on the renin-angiotensin system. International journal of molecular sciences. 2019 Feb 1;20(3):629.
70) Quesada O, Claggett B, Rodriguez F, Cai J, Moncrieft AE, Garcia K, Del Rios Rivera M, Hanna DB, Daviglus ML, Talavera GA, Bairey Merz CN. Associations of insulin resistance with systolic and diastolic blood pressure: a study from the HCHS/SOL.Hypertension. 2021 Sep;78(3):716-25.